The association between heart failure and incident cancer in women: an analysis of the Women's Health Initiative.


Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
10 2021
Historique:
revised: 28 04 2021
received: 05 01 2021
accepted: 29 04 2021
pubmed: 2 5 2021
medline: 1 4 2022
entrez: 1 5 2021
Statut: ppublish

Résumé

There is conflicting evidence whether heart failure (HF) is a risk factor for incident cancer. Despite population-based cohorts demonstrating this association, an analysis of the Physician's Health Study found no association in a cohort of mostly healthy males. We investigated the association of HF with incident cancer among a large cohort of post-menopausal women. A prospective cohort study of 146 817 post-menopausal women age 50 to 79 years enrolled in the Women's Health Initiative from 1993-1998, and followed through 2015. The primary exposure was adjudicated incident HF diagnosis, including preserved and reduced ejection fraction in a sub-cohort. The primary outcome was adjudicated incident total and site-specific cancers. Hazard ratios were calculated using multivariable-adjusted Cox proportional hazard regression models. Over a median follow-up of 8.4 years, 3272 and 17 474 women developed HF and cancer, respectively. HF developed in 235 women prior to cancer. HF was associated with subsequent incident cancer [hazard ratio (HR) 1.28, 95% confidence interval (CI) 1.11-1.48]. Associations were observed for obesity-related cancers (HR 1.24, 95% CI 1.02-1.51), as well as lung and colorectal cancers (HR 1.58, 95% CI 1.09-2.30 and HR 1.52, 95% CI 1.02-2.27, respectively). HF with preserved ejection fraction (HR 1.34, 95% CI 1.06-1.67), but not HF reduced ejection fraction (HR 0.99, 95% CI 0.74-1.34), was associated with total cancer. Heart failure was associated with an increase in cancer diagnoses in post-menopausal women. This association was strongest for lung cancer. Further research is needed to appreciate the underlying mechanisms responsible for this association.

Identifiants

pubmed: 33932263
doi: 10.1002/ejhf.2207
pmc: PMC8591611
mid: NIHMS1754254
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1712-1721

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201600002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600018C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600004C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600003C
Pays : United States
Organisme : NINR NIH HHS
ID : F31 NR018588
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 European Society of Cardiology.

Références

Ann Epidemiol. 2003 Oct;13(9 Suppl):S122-8
pubmed: 14575944
J Am Coll Cardiol. 2004 Apr 21;43(8):1432-8
pubmed: 15093880
Circulation. 2011 May 10;123(18):2006-13; discussion 2014
pubmed: 21555723
Control Clin Trials. 1998 Feb;19(1):61-109
pubmed: 9492970
Circulation. 2019 Mar 5;139(10):1289-1299
pubmed: 30586730
Circ Res. 2013 Aug 30;113(6):646-59
pubmed: 23989710
Obes Rev. 2013 Aug;14(8):665-78
pubmed: 23615120
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
JAMA. 2004 Jul 21;292(3):344-50
pubmed: 15265849
J Am Coll Cardiol. 2016 Jul 19;68(3):265-271
pubmed: 27417004
Circ Heart Fail. 2016 Oct;9(10):
pubmed: 27682440
Int J Cardiol. 2019 Sep 1;290:106-112
pubmed: 31104823
J Intern Med. 2001 Jun;249(6):519-26
pubmed: 11422658
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1532-44
pubmed: 20501755
Circulation. 2018 Aug 14;138(7):678-691
pubmed: 29459363
J Am Coll Cardiol. 2018 Apr 10;71(14):1501-1510
pubmed: 29622155
Eur J Heart Fail. 2016 Mar;18(3):260-6
pubmed: 26751260
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
Ann Epidemiol. 2003 Oct;13(9 Suppl):S18-77
pubmed: 14575939
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
J Am Coll Cardiol. 2012 Mar 13;59(11):998-1005
pubmed: 22402071
JACC CardioOncol. 2019 Dec 17;1(2):196-205
pubmed: 34396183
IARC Monogr Eval Carcinog Risks Hum. 2010;96:3-1383
pubmed: 21735939
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Circulation. 2000 Sep 5;102(10):1126-31
pubmed: 10973841
J Natl Cancer Inst. 2015 Mar 10;107(2):
pubmed: 25757865
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
JAMA Cardiol. 2019 Jan 1;4(1):25-33
pubmed: 30566180
Eur Heart J. 2008 Feb;29(3):339-47
pubmed: 18156618
Hypertens Res. 2017 Sep;40(9):831-836
pubmed: 28381869
N Engl J Med. 1989 Jul 20;321(3):129-35
pubmed: 2664509
N Engl J Med. 2017 Jul 13;377(2):111-121
pubmed: 28636844
J Am Coll Cardiol. 2013 Sep 3;62(10):881-6
pubmed: 23810869
JAMA. 2006 Nov 8;296(18):2209-16
pubmed: 17090767
Eur J Heart Fail. 2018 May;20(5):879-887
pubmed: 29464808
Circulation. 2009 Jun 23;119(24):3070-7
pubmed: 19506115
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Circ Heart Fail. 2008 Jul;1(2):91-7
pubmed: 19300532
Lancet. 2017 Oct 21;390(10105):1833-1842
pubmed: 28855077
JAMA Cardiol. 2018 Oct 1;3(10):1011-1019
pubmed: 30140928

Auteurs

Douglas J Leedy (DJ)

Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.

Kerryn W Reding (KW)

Department of Biobehavioral Nursing and Health Informatics, University of Washington School of Nursing, Seattle, WA, USA.
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, WA, USA.

Alexi L Vasbinder (AL)

Department of Biobehavioral Nursing and Health Informatics, University of Washington School of Nursing, Seattle, WA, USA.

Garnet L Anderson (GL)

Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, WA, USA.

Ana Barac (A)

MedStar Heart and Vascular Institute, Medstar Washington Hospital Center, Georgetown University, Washington, DC, USA.

Jean Wactawski-Wende (J)

Department of Epidemiology and Environmental Health, University of Buffalo, Buffalo, NY, USA.

Aladdin H Shadyab (AH)

Department of Family Medicine and Public Health, University of California San Diego School of Medicine, San Diego, CA, USA.

Charles B Eaton (CB)

Department of Family Medicine and Epidemiology, Alpert Medical School of Brown University, Providence, RI, USA.

Wayne C Levy (WC)

Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.

LiHong Qi (L)

Department of Public Health Sciences, University of California Davis School of Medicine, Sacramento, CA, USA.

Richard K Cheng (RK)

Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH